001     23152
005     20200402210322.0
024 7 _ |2 pmid
|a pmid:22959622
024 7 _ |2 DOI
|a 10.1016/j.str.2012.08.005
024 7 _ |2 WOS
|a WOS:000309787900021
024 7 _ |a altmetric:934172
|2 altmetric
037 _ _ |a PreJuSER-23152
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |0 P:(DE-Juel1)VDB94799
|a Lecher, J.
|b 0
|u FZJ
245 _ _ |a An RTX toxin transporters tether ist substrate prior to secretion via the unique function of ist N- terminal domain
260 _ _ |a London [u.a.]
|b Elsevier Science
|c 2012
300 _ _ |a 1778 - 1787
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |0 26723
|a Structure
|v 20
|y 10
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Type 1 secretion systems (T1SS) catalyze the one step protein transport across the membranes of Gram-negative bacteria and are composed of an outer membrane protein, a membrane fusion protein and an ABC transporter. The ABC transporter consists of the canonical nucleotide binding and transmembrane domains. For the toxin hemolysin A (HlyA), the ABC transporter HlyB carries an additional, N-terminal domain sharing about 40% homology to C39 peptidases, but this "C39-like domain" (CLD) is suggested to feature another, yet unknown function. Our functional and structural analysis demonstrates that the CLD is essential for secretion and that it specifically interacts with the unfolded state of HlyA. We determined the nuclear magnetic resonance structure of the CLD as well as the substrate-binding region within the CLD. This mode of action, represents a mechanism within T1SS and answers the question, how a large and unfolded substrate is protected inside the cells during secretion.
536 _ _ |0 G:(DE-Juel1)FUEK409
|2 G:(DE-HGF)
|a Funktion und Dysfunktion des Nervensystems
|c P33
|x 0
536 _ _ |0 G:(DE-Juel1)FUEK505
|a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|c P45
|x 1
588 _ _ |a Dataset connected to Pubmed
700 1 _ |0 P:(DE-HGF)0
|a Schwarz, C.K.W.
|b 1
700 1 _ |0 P:(DE-Juel1)VDB21601
|a Stoldt, M.
|b 2
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Smits, S.H.J.
|b 3
700 1 _ |0 P:(DE-Juel1)132029
|a Willbold, D.
|b 4
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Schmitt, L.
|b 5
773 _ _ |0 PERI:(DE-600)2031189-8
|a 10.1016/j.str.2012.08.005
|g Vol. 20, p. 1778 - 1787
|p 1778 - 1787
|q 20<1778 - 1787
|t Structure
|v 20
|x 0969-2126
|y 2012
856 7 _ |u http://dx.doi.org/10.1016/j.str.2012.08.005
909 C O |o oai:juser.fz-juelich.de:23152
|p VDB
913 1 _ |0 G:(DE-Juel1)FUEK409
|1 G:(DE-HGF)POF2-330
|2 G:(DE-HGF)POF2-300
|b Gesundheit
|k P33
|l Funktion und Dysfunktion des Nervensystems
|v Funktion und Dysfunktion des Nervensystems
|x 0
913 1 _ |0 G:(DE-Juel1)FUEK505
|1 G:(DE-HGF)POF2-450
|2 G:(DE-HGF)POF2-400
|b Schlüsseltechnologien
|k P45
|l Biologische Informationsverarbeitung
|v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung
|x 1
913 2 _ |0 G:(DE-HGF)POF3-551
|1 G:(DE-HGF)POF3-550
|2 G:(DE-HGF)POF3-500
|a DE-HGF
|b Key Technologies
|l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|v Functional Macromolecules and Complexes
|x 0
914 1 _ |y 2012
915 _ _ |a Peer review unknown
|0 StatID:(DE-HGF)0040
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|g ICS
|k ICS-6
|l Strukturbiochemie
|x 0
970 _ _ |a VDB:(DE-Juel1)140117
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21